If you’ve been following the latest developments in Alzheimer’s research, you’ve probably heard about blood-based biomarkers. These tests measure proteins associated with Alzheimer’s disease right from a simple blood draw, making them far more accessible than traditional methods like spinal taps or brain scans.
